Stockscreener 앱 받기
1.02
4.67%
0.0455
시간 외 거래:
1.01
-0.01
-0.98%
전일 마감가:
$0.9745
열려 있는:
$0.972
하루 거래량:
573.92K
Relative Volume:
1.05
시가총액:
$129.80M
수익:
-
순이익/손실:
$-18.43M
주가수익비율:
-6.5469
EPS:
-0.1558
순현금흐름:
$-12.87M
1주 성능:
+0.99%
1개월 성능:
+5.42%
6개월 성능:
-28.67%
1년 성능:
-35.44%
1일 변동 폭
$0.9507
$1.06
1주일 범위
$0.91
$1.06
52주 변동 폭
$0.8663
$2.35
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Compare TLSA vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.02 | 142.53M | 0 | -18.43M | -12.87M | -0.1558 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news
Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration - Proactive financial news
Tiziana Life Sciences initiated with a Buy at BTIG - TipRanks
This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
BTIG Initiates Tiziana Life Sciences at Buy With $7 Price Target - marketscreener.com
BTIG initiates Tiziana Life Sciences stock with buy on MS drug - Investing.com
Wall Street ends on a mixed note as Dow gains despite semiconductor slump - Proactive financial news
Market movers: Strategy, Bitmine, Tiziana Life Sciences... - Proactive financial news
Tiziana (NASDAQ: TLSA) highlights intranasal ALS trial and MS data - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026 - TipRanks
Tiziana Life Sciences Ltd (TLSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Tiziana Life Sciences (TLSA) insider adds 42,357 shares via Panetta Partners - Stock Titan
Tiziana Life Sciences Ltd (TLSA) director adds 15,000 shares in open-market buy - Stock Titan
Tiziana Life Sciences CEO & Executive Director Acquires 18% More Stock - simplywall.st
Tiziana Life Sciences (TLSA) CEO Boosts Stake Amid Unprofitable Operations and Low Valuation - GuruFocus
TLSA | Tiziana Life Sciences Ltd. Insider Trading - Quiver Quantitative
Insider Buying: Tiziana Life Sciences (NASDAQ:TLSA) CEO Purchases 83,807 Shares of Stock - marketbeat.com
Ivor Elrifi Acquires 237,616 Shares of Tiziana Life Sciences (NASDAQ:TLSA) Stock - marketbeat.com
Tiziana Life Sciences : Announces Purchase of Shares by Chief Executive Officer - marketscreener.com
Tiziana Life Sciences (Nasdaq: TLSA) CEO boosts stake with 321,423-share buy - Stock Titan
Tiziana Life Sciences announces CEO share purchase - Proactive financial news
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - The Manila Times
Tiziana Life Sciences (NASDAQ:TLSA) CEO Ivor Elrifi Purchases 667,000 Shares - MarketBeat
Tiziana Life Sciences (TLSA) CEO buys 667,000 new shares - Stock Titan
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses - The Globe and Mail
Tiziana Life Sciences (TLSA) CEO Boosts Stake Amid Positive MS T - GuruFocus
Tiziana Life Sciences (NASDAQ: TLSA) CEO purchases 667,000 shares at $1 - Stock Titan
Tiziana CEO adds to holdings - Proactive financial news
Tiziana Life Sciences (TLSA) Slips 5.8% to $0.97, Approaches Key Support at $0.92Reversal Setup Alerts - dars.gov.et
Tiziana Life Sciences Ltd Revenue Breakdown – NASDAQ:TLSA - TradingView
Small cap wrap: Medicus Pharma, Tiziana Life Sciences, Namibia Critical Metals... - Proactive financial news
Tiziana Life Sciences Posts Reproducible PET Evidence of Reduced Brain Inflammation in Third MSA Patient - TipRanks
Tiziana Life Sciences Reports Reduced Neuroinflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab - Quiver Quantitative
Reduced brain inflammation seen in MSA trial at Tiziana (Nasdaq: TLSA) - Stock Titan
Tiziana Reports Reduction in Brain Inflammation in Third - GlobeNewswire
Tiziana reports reduced brain inflammation in t... - Pluang
Tiziana Life Sciences Ltd (TLSA) Institutional Confidence - TradingKey
Tiziana Life Sciences Ltd (TLSA) Cash Flow - TradingKey
Tiziana Life Sciences Ltd (TLSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tiziana Life Sciences Ltd (TLSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TLSA|Tiziana Life Sciences Ltd|Price:0.985|Chg%:-0.005 - TradingKey
Tiziana Life Sciences Ltd (TLSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tiziana Life Sciences Ltd (TLSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tiziana Life Sciences Ltd (TLSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TLSA|Tiziana Life Sciences Ltd|Price:0.910|Chg%:+0.018 - TradingKey
TradingKey - TradingKey
Tiziana Life Sciences Ltd. Revenue Breakdown – FWB:0RP - TradingView
Tiziana Life Sciences Ltd. Revenue Breakdown – GETTEX:0RP - TradingView
Tiziana Life Sciences (TLSA) insider awarded 42,357 shares of common stock - Stock Titan
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tiziana Life Sciences Ltd 주식 (TLSA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Elrifi Ivor | Chief Executive Officer |
Aug 04 '26 |
Buy |
0.97 |
83,807 |
81,293 |
4,556,068 |
| Elrifi Ivor | Chief Executive Officer |
Aug 03 '26 |
Buy |
1.00 |
667,000 |
667,000 |
4,472,261 |
0.86%
0.31%
자본화:
|
볼륨(24시간):